Clinical stage B non-seminomatous germ cell testis cancer: The Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissection
- 30 September 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (10), 1599-1604
- https://doi.org/10.1016/0959-8049(95)00330-l
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Primary Chemotherapy for Stage II Nonseminomatous Germ Cell Tumors of the TestisJournal of Urology, 1994
- Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic BenefitBritish Journal of Urology, 1993
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?Journal of Clinical Oncology, 1991
- Nerve-Sparing Retroperitoneal Lymphadenectomy with Preservation of EjaculationJournal of Urology, 1990
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987
- Selecting initial therapy. Seminoma and nonseminomaCancer, 1987
- COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTISThe Lancet, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977